TNF-α reduces the Na+/K+ ATPase activity in LLC-PK1 cells by activating caspases and JNK and inhibiting NF-κB

Cell Biology International

Volumn 34, Issue 6, 2010, Pages 607-613

  Ramia, Nancy ^a   Kreydiyyeh, Sawsan Ibrahim ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

c JNK; Caspases; LLC PK1; Na+ K+ ATPase; NF B; TNF

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CASPASE 3; ENZYME INHIBITOR; FK 009; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; PROTEIN C JUN; PYRROLIDINE DITHIOCARBAMATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CASPASE; CYSTEINE PROTEINASE INHIBITOR; PEPTIDE CHLOROMETHYL KETONE; PYRROLIDINE DERIVATIVE; PYRROLIDINE DITHIOCARBAMIC ACID; STRESS ACTIVATED PROTEIN KINASE; THIOCARBAMIC ACID DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SWINE; ANIMAL; CELL STRAIN; DRUG ANTAGONISM; METABOLISM;

STROPHANTHUS GRATUS;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; ANTHRACENES; CASPASES; CYSTEINE PROTEINASE INHIBITORS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LLC-PK1 CELLS; NF-KAPPA B; PYRROLIDINES; SIGNAL TRANSDUCTION; SODIUM-POTASSIUM-EXCHANGING ATPASE; SWINE; THIOCARBAMATES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955064677     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20090093     Document Type: Article

References (23)

1. Arrebola F, Zabiti S, Canizares FJ, Cubero MA, Crespo PV, Fernandez-Segura E. Changes in intracellular sodium, chlorine, and potassium concentrations in staurosporine-induced apoptosis. J Cell Physiol 2005;204:500-7.
2. Baud L, Fouqueray B, Philippe C, Amrani A. Tumor necrosis factor alpha and mesangial cells. Kidney Int. 1992; 41:600-3.
3. Beg AA, Baltimore D. An essential role for NF-kappaB in preventing TNFalpha-induced cell death. Science 1996;274:782-4.
4. Bojes HK, Germolec DR, Simeonova P, Bruccolrei A, Schoonhoven R, Luster MI, Thurman RG. Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator WY-14 643. Carcinogenesis 1997;18:669-74.
5. Cardone MH, Salvesen GS, Widmann C, Johnson G, Frisch SM. The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell 1997;90:315-23.
6. DiPetrillo K, Coutermarsh B, Gesek FA. Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes. Am J Physiol Renal Physiol 2003;284:F113-2.
7. DiPetrillo K, Coutermarsh B, Soucy N, Hwa J, Gesek F. Tumor necrosis factor induces sodium retention in diabetic rats through sequential effects on distal tubule cells. Kidney Int. 2004;65:1676-83.
8. Guo YL, Baysal K, Kang B, Yang LJ, Williamson JR. Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J Biol Chem 1998;273:4027-34.
9. Henkler F, Baumann B, Fotin-Mleczek M, Weingärtner M, Schwenzer R, Peters N, Graness A, Wirth T, Scheurich P, Schmid JA, Wajant H. Caspase-mediated cleavage converts the tumor necrosis factor (TNF) receptor-associated factor (TRAF)-1 from a selective modulator of TNF receptor signaling to a general inhibitor of NF-kappaB activation. J Biol Chem 2003;278:29216-30.
10. κB activity and cell viability. Mol Biol Cell 2002;13:2933-45.
11. Jäättelä M. Biologic activities and mechanisms of action of tumor necrosis factor-a/cachectin. Lab Invest 1991;64:724-42.
12. Lenczowski JM, Dominguez L, Eder AM, King LB, Zacharchuk CM, Ashwell JD. Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis. Mol Cell Biol 1997;17:170-81.
13. Liu Z, Hsu H, Goeddel D, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappa B activation prevents cell death. Cell 1996;87:565-76.
14. Martinez-Mas JV, Peinado-Onsurbe J, Ruiz-Montasell B, Felipe A, Javier Casado F, Pastor-Anglada M. Na+,K+-ATPase expression during the early phase of liver growth after partial hepatectomy. FEBS Letters. 1995;362:85-88.
15. Martinon F, Holler N, Richard C, Tschopp J. Activation of a proapoptotic amplification loop through inhibition of NF-kappaB-dependent survival signals by caspase-mediated inactivation of RIP. FEBS Lett. 2000;468:134-6.
16. Mora C, Navarro JF. Inflammation and pathogenesis of diabetic nephropathy. Metabolism 2004;53:265-6.
17. Nishina H, Fischer KD, Radvanyi L, Shahinian A, Hakem R, Rubie EA, Bernstein A, Mak TW, Woodgett JR, Penninger JM. Stresssignalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 1997;385:350-353.
18. +-ATPase may be one mechanism contributing to potassium efflux and cell shrinkage in CD95-induced apoptosis. Apoptosis 2000;5:153-63.
19. Nørby JG. Coupled assay of Na+,K+-ATPase activity. In Fleischer S, Fleisher B, editors. Methods in enzymology biomembranes part P ATP-driven pumps and related transport: the Na,K-pump. San Diego: Academic Press; 1988. vol 156, pp 116-9.
20. Sethi G, Ahn KS, Xia D, Kurie JM, Aggarwal BB. Targeted deletion of MKK4 gene potentiates TNF-induced apoptosis through the downregulation of NF-kappa B activation and NF-kappa B-regulated antiapoptotic gene products. J Immunol 2007;179:1926-33.
21. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science. 1996;274(5288):787-9.
22. Vielhauer V, Mayadas TN. Functions of TNF and its receptors in renal disease: distinct roles in inflammatory tissue injury and immune regulation. Semin Nehprol 2007;27:286-308.
23. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signalling. Cell Death and Differ 2003;10:45-65.